Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

Nov.14.2025
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Key Point

 

  • $200M enforcement funding from tobacco user fees to crack down on illegal ENDS products.
  • $2M for China-focused task force led by DOJ, DHS, and FDA.
  • Expanded enforcement to include flavored disposable ENDS products within 12 months.
  • Semi-annual reports required from FDA to Congress.
  • Import authority strengthened by adding “tobacco products” to items FDA can refuse at the border.
  • Retailer education mandate requiring FDA to outline guidance within 180 days.

 


 

2Firsts, November 14, 2025 — According to the U.S. Congress website, U.S. President Donald Trump signed the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (H.R. 5371) on November 12, officially ending the 43-day federal government shutdown. The omnibus legislation includes full-year funding for several key federal departments.

 

Part B of the law — the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 (hereinafter “the FDA Appropriations Act”) — contains Section 772, which establishes new regulatory and enforcement measures targeting the U.S. e-cigarette and ENDS market.

 

According to the text of S.2256 – Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026, Section 772 lays out a detailed enforcement and reporting framework for the U.S. Food and Drug Administration (FDA) concerning e-cigarettes, vapes, and other electronic nicotine delivery systems (ENDS).

 

Under subsection (a), of the amounts made available in the Act under the heading “Department of Health and Human Services—Food and Drug Administration—Salaries and Expenses” that are derived from tobacco product user fees authorized by 21 U.S.C. 387s, not less than $200,000,000 must be used by the Commissioner of Food and Drugs for enforcement activities related to e-cigarettes, vapes, and other ENDS, including activities under section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)). Of this amount, not less than $2,000,000 is reserved to continue supporting the federal multi-agency task force led by the Department of Justice, Department of Homeland Security, and the FDA, aimed at applying all available criminal and civil tools against the illegal manufacture, importation, distribution, and sale of e-cigarettes, vapes, and other ENDS products from the Republic of China and other foreign countries.

 

Under subsection (b), no later than 365 days after enactment, the Commissioner of Food and Drugs must update the FDA document titled “Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization,” published in January 2020 and updated in April 2020. The update must expand FDA’s prioritized enforcement to include flavored disposable ENDS products, in addition to cartridge-based products, and must define the term “disposable ENDS product.”

 

Under subsection (c), the Commissioner of Food and Drugs must submit a semi-annual written report to the Committees on Appropriations of both Houses of Congress on the progress made by the Center for Tobacco Products in removing all illegal ENDS products from the market. The initial report must be submitted no later than 180 days after enactment.

 

Subsection (d) amends section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) by striking the phrase “drug or device” in the seventh, eighth, ninth, and tenth sentences and replacing it with “drug, device, or tobacco product.” This change explicitly brings tobacco products within the scope of that statutory provision.

 

Finally, under subsection (e), within 180 days, the FDA must submit a report to the Appropriations Committees of both Houses of Congress detailing the Agency’s activities to educate retailers in determining which products are legal for sale.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Pakistan Senate health panel weighs possible vape ban
Pakistan Senate health panel weighs possible vape ban
Sources say Pakistan’s Senate Standing Committee on Health is deliberating whether to impose a ban on vaping products, after holding a meeting on the health implications of vaping and the rising use of e-cigarettes nationwide.
Mar.04 by 2FIRSTS.ai
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
Korea Disease Control and Prevention Agency’s Youth Health Panel Survey (2025) Final Results Report says key adolescent health indicators worsen as students move up grade levels. By 11th grade, lifetime tobacco experience rose to 9.59%. Among 11th-grade girls, current use of liquid e-cigarettes (1.54%) surpassed conventional cigarettes (1.33%) for the first time.
Feb.10 by 2FIRSTS.ai
Philip Morris Korea Launches New IQOS ILUMA i “Electric Purple” Color Edition
Philip Morris Korea Launches New IQOS ILUMA i “Electric Purple” Color Edition
Philip Morris Korea said it has launched a new color edition of its heated tobacco device brand IQOS, called “IQOS ILUMA i Electric Purple.” The new color has been added to the IQOS ILUMA i series and applies to the Prime, standard, and One variants. The product is being sold through the IQOS website and nine IQOS directly operated stores across South Korea.
Mar.12 by 2FIRSTS.ai
Belarus opts for stricter regulation instead of full e-cigarette ban
Belarus opts for stricter regulation instead of full e-cigarette ban
Belarus rejects full e-cigarette ban, opts for stricter regulation. Officials plan to restrict wholesaling and strengthen import and production permits.
Mar.04 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
Vape sellers sue to block Texas law banning e-liquids from China and other “foreign adversaries”
Vape sellers sue to block Texas law banning e-liquids from China and other “foreign adversaries”
A group of vape distributors and retailers has sued to block enforcement of a Texas law that criminalizes selling or marketing vape products containing e-liquids made wholly or partly in China or in countries designated as “foreign adversaries” by the U.S. Commerce Secretary. The plaintiffs argue the law violates the U.S. Constitution because only Congress may regulate foreign commerce.
Feb.03 by 2FIRSTS.ai